King Luther Capital Management Corp Emergent Bio Solutions Inc. Transaction History

King Luther Capital Management Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$56.61 - $80.46 $6.25 Million - $8.89 Million	-110,491 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$86.23 - $125.19 $1.02 Million - $1.48 Million	-11,796 Reduced 9.65%	110,491 $10.3 Million
Q4 2020 Feb 10, 2021	BUY	$79.17 - $111.47 $2.52 Million - $3.55 Million	31,885 Added 35.27%	122,287 $11 Million
Q3 2020 Nov 12, 2020	SELL	$81.91 - $134.94 $1.33 Million - $2.18 Million	-16,177 Reduced 15.18%	90,402 $9.34 Million
Q2 2020 Aug 12, 2020	BUY	$54.33 - $89.52 $2.64 Million - $4.35 Million	48,604 Added 83.84%	106,579 $8.43 Million
Q1 2020 May 13, 2020	BUY	$49.34 - $68.76 $519,056 - $723,355	10,520 Added 22.17%	57,975 $3.35 Million
Q4 2019 Feb 12, 2020	BUY	$51.21 - $59.06 $394,317 - $454,762	7,700 Added 19.37%	47,455 $2.56 Million
Q3 2019 Nov 12, 2019	BUY	$40.6 - $57.2 $1.32 Million - $1.86 Million	32,460 Added 444.96%	39,755 $2.08 Million
Q2 2019 Aug 12, 2019	BUY	$39.92 - $53.86 $291,216 - $392,908	7,295 New	7,295 $352,000

160

33.8M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $438M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of King Luther Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on King Luther Capital Management Corp with notifications on news.